BDTX
Black Diamond Therapeutics Inc
NASDAQ: BDTX · HEALTHCARE · BIOTECHNOLOGY
$2.65
+3.11% today
Updated 2026-04-30
Market cap
$170.15M
P/E ratio
7.62
P/S ratio
2.43x
EPS (TTM)
$0.39
Dividend yield
—
52W range
$1 – $5
Volume
0.7M
Black Diamond Therapeutics Inc (BDTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $8.02M | $51.83M | $158.29M | $329.67M | $247.68M | $156.25M | $158.57M | $122.64M |
| Cash & equivalents | $7.88M | $51.66M | $154.67M | $34.60M | $65.80M | $34.31M | $56.22M | $36.44M |
| Current assets | $7.91M | $51.68M | $155.71M | $319.55M | $215.70M | $127.71M | $134.03M | $101.18M |
| Total liabilities | $14.70M | $67.37M | $205.45M | $21.91M | $51.78M | $40.56M | $41.83M | $39.35M |
| Current liabilities | $2.23M | $2.58M | $4.86M | $14.22M | $23.64M | $15.26M | $19.65M | $20.57M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Shareholder equity | $-6.67M | $-15.54M | $-47.16M | $307.76M | $195.90M | $115.69M | $116.74M | $83.28M |
| Retained earnings | $-6.78M | $-15.71M | $-50.97M | $-118.22M | $-243.82M | $-334.99M | $-417.43M | $-487.11M |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |